Emerging Infectious Diseases Program Programme
Established to contribute to the global health security
Ebola and Marburg Research
Part of the multisite protocol that contributed to the approved Ebola Zaire preventive vaccines Zabdeno and Mvabea
Establishment of the Joint Mobile Emerging Diseases Intervention Clinical Capability
To rapidly deploy a therapeutic treatment agent during an Ebola outbreak and execute a clinical trial.
Schistosomiasis Vaccine Trial
MUWRP started a Phase I/II Study of the Safety, Immunogenicity, and Efficacy of a candidate Intestinal Schistosomiasis Vaccine in Healthy Ugandan Adults
Support to the Ebola Response in Mubende and Kassanda districts
Led in case management and health worker training to the Ebola National Response Program
Joint Mobile Emerging Disease Intervention Clinical Capability
The Joint Mobile Emerging Disease Intervention Clinical Capability (JMEDICC) transformed into the Austere Environment Consortium for Enhanced Sepsis Outcomes (ACESO) Uganda, signifying a strategic shift towards pioneering research in emerging technologies.
Change of Organizational Name
MUWRP has transitioned from "Makerere University Walter Reed Project" to "Makerere University Walter Reed Program" to better reflect its growth and expanded operations. Additionally, MUWRP updated its logo to enhance visual impact and align with the new branding strategy.
